1.
Savić M. Neurotoxicity De-Risking in Preclinical Drug Discovery. arhfarm [Internet]. 2022 Oct. 11 [cited 2026 Jul. 12];72(Suppl. 4):S163-S164. Available from: https://asistent.ceon.rs/index.php/arhfarm/article/view/38997